Literature DB >> 8350635

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

M Rodriguez1, B W Scheithauer, G Forbes, P J Kelly.   

Abstract

The ultrastructural features of 11 stereotaxic brain biopsy specimens that demonstrated inflammatory primary demyelination consistent with acute multiple sclerosis were examined. Uniform widening of inner myelin lamellae (biphasic myelinopathy) and degeneration of inner glial loops ("dying-back" oligodendrogliopathy) were early pathologic abnormalities that antedated complete destruction of myelin sheaths. Perivascular inflammatory cells (lymphocytes, macrophages, and occasional plasma cells) were in intimate contact with degenerating myelin sheaths. The response of astrocytes was prominent, even in areas of minimal demyelination. Oligodendrocytes were morphologically preserved in early lesions but proliferated at the periphery of active lesions. Thinly myelinated axons indicative of central nervous system-type remyelination by oligodendrocytes were observed primarily at the edge of plaques. Disturbances of the myelinating function of oligodendrocytes--unaccompanied by death of these cells--may be among the earliest pathologic features in multiple sclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8350635     DOI: 10.1016/s0025-6196(12)60597-7

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  25 in total

1.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

2.  p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells.

Authors:  O Eizenberg; A Faber-Elman; E Gottlieb; M Oren; V Rotter; M Schwartz
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 3.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.

Authors:  B Yacyshyn; J Meddings; D Sadowski; M B Bowen-Yacyshyn
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 5.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 6.  Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Authors:  S F Hunter; M Rodriguez
Journal:  Springer Semin Immunopathol       Date:  1995

7.  Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Authors:  J H Noseworthy; P C O'Brien; B G van Engelen; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 8.  Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Authors:  B G van Engelen; D J Miller; K D Pavelko; O R Hommes; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 9.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

10.  Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.

Authors:  Heba R Ghaiad; Mohammed M Nooh; Maha M El-Sawalhi; Amira A Shaheen
Journal:  Mol Neurobiol       Date:  2016-04-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.